Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Pierer Mobility, Marinomed (16/09/2025)

21.09.2025

Pierer Mobility: Petra Preining joins the Executive Board of PIERER Mobility AG and KTM AG as new Chief Financial Officer. She will take over the areas of accounting, tax, treasury, controlling, risk management, investor relations and IT on 16 September 2025. As a proven financial expert, she has many years of international experience in various companies. Since 2022, she has been CFO of the listed company AT&S Austria Technologie & Systemtechnik AG, and prior to that she held the same position at the listed company Semperit AG Holding.
Pierer Mobility: weekly performance: 0.25%

Marinomed: Marinomed Biotech AG resolved to increase the Company's share capital by EUR 61.607 to EUR 1.839.940 by issuing 61.607 new no-par value bearer shares against cash contributions. The issue price per new share is EUR 17,50 so that the total issue price amounts to EUR 1,078,123.  All 61.607 new shares have been subscribed at these issue terms and conditions by a total of nine investors.
Marinomed Biotech: weekly performance: -3.73%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/09/2025)


Partners









latest 21st Austria

21st Austria weekly - Pierer Mobility, Marinomed (16/09/2025)


21.09.2025, 1114 Zeichen



Pierer Mobility: Petra Preining joins the Executive Board of PIERER Mobility AG and KTM AG as new Chief Financial Officer. She will take over the areas of accounting, tax, treasury, controlling, risk management, investor relations and IT on 16 September 2025. As a proven financial expert, she has many years of international experience in various companies. Since 2022, she has been CFO of the listed company AT&S Austria Technologie & Systemtechnik AG, and prior to that she held the same position at the listed company Semperit AG Holding.
Pierer Mobility: weekly performance: 0.25%

Marinomed: Marinomed Biotech AG resolved to increase the Company's share capital by EUR 61.607 to EUR 1.839.940 by issuing 61.607 new no-par value bearer shares against cash contributions. The issue price per new share is EUR 17,50 so that the total issue price amounts to EUR 1,078,123.  All 61.607 new shares have been subscribed at these issue terms and conditions by a total of nine investors.
Marinomed Biotech: weekly performance: -3.73%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/09/2025)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

SportWoche ÖTV-Spitzentennis Podcast: Es geht weiter nach oben, Anastasia Potapowa und Lukas Neumayer holen wichtige Punkte




 

Bildnachweis

Aktien auf dem Radar:AT&S, UBM, Strabag, Zumtobel, Lenzing, Agrana, Uniqa, Wolford, RBI, OMV, Porr, Palfinger, Fabasoft, Rosgix, Erste Group, Kapsch TrafficCom, Polytec Group, Wiener Privatbank, Warimpex, Frauenthal, BKS Bank Stamm, Oberbank AG Stamm, Amag, CA Immo, EuroTeleSites AG, CPI Europe AG, Österreichische Post, Semperit, Telekom Austria, Deutsche Post, Caterpillar.


Random Partner

VIG
Die Vienna Insurance Group (VIG) ist mit rund 50 Konzerngesellschaften und mehr als 25.000 Mitarbeitern in 30 Ländern aktiv. Bereits seit 1994 notiert die VIG an der Wiener Börse und zählt heute zu den Top-Unternehmen im Segment “prime market“ und weist eine attraktive Dividendenpolitik auf.

>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten